•
Mar 31

Natera Q1 2025 Earnings Report

Natera reported its financial results for the first quarter ended March 31, 2025.

Key Takeaways

Natera reported strong first quarter 2025 results with significant growth in total revenue and product revenue, driven by increased test volume and improved average selling prices. The company also saw an increase in gross profit and managed its net loss.

Total revenues increased by 36.5% to $501.8 million in Q1 2025 compared to $367.7 million in Q1 2024.

Product revenues grew by 37.1% to $500.0 million in Q1 2025, up from $364.7 million in the prior year period.

Gross profit rose to $316.8 million in Q1 2025, resulting in a gross margin of 63.1%.

Net loss for Q1 2025 was $66.9 million, or ($0.50) per diluted share, compared to a net loss of $67.6 million, or ($0.56) per diluted share, in Q1 2024.

Total Revenue
$502M
Previous year: $368M
+36.5%
EPS
-$0.5
Previous year: -$0.56
-10.7%
Tests Processed
855.1K
Previous year: 735.8K
+16.2%
Tests Accessioned
840.8K
Previous year: 718.7K
+17.0%
Total Tests Reported
804.8K
Previous year: 679.4K
+18.5%
Gross Profit
$317M
Previous year: $209M
+51.9%
Cash and Equivalents
$974M
Previous year: $883M
+10.3%
Total Assets
$1.73B
Previous year: $1.47B
+18.0%

Natera

Natera

Natera Revenue by Segment

Forward Guidance

Natera provided its financial outlook for the full year 2025, anticipating strong revenue growth, continued favorable gross margins, and positive net cash inflow.

Positive Outlook

  • Anticipates 2025 total revenue between $1.94 billion and $2.02 billion.
  • Projects 2025 gross margin to be approximately 60% to 64% of revenues.
  • Forecasts positive net cash inflow for 2025.

Challenges Ahead

  • Estimates 2025 selling, general and administrative costs to be approximately $0.975 billion to $1.05 billion.
  • Estimates 2025 research and development costs to be $550 million to $590 million.

Revenue & Expenses

Visualization of income flow from segment revenue to net income